Accurately Assessing the Expected Impact of Universal First RSV Season Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants.
The Journal of infectious diseases（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要